Ausgabe 9/2016
Inhalt (16 Artikel)
TRPM8: a potential target for cancer treatment
Zhaoguo Liu, Hongyan Wu, Zhonghong Wei, Xu Wang, Peiliang Shen, Siliang Wang, Aiyun Wang, Wenxing Chen, Yin Lu
Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets
C. Schindlbeck, U. Andergassen, J. Jueckstock, B. Rack, W. Janni, U. Jeschke
The emerging roles of exosomes in tumor–stroma interaction
Hailong Fu, Huan Yang, Xu Zhang, Wenrong Xu
Feasibility of induced metabolic bioluminescence imaging in advanced ovarian cancer patients: first results of a pilot study
Marco Johannes Battista, Kristina Goetze, Marcus Schmidt, Cristina Cotarelo, Veronika Weyer-Elberich, Annette Hasenburg, Wolfgang Mueller-Klieser, Stefan Walenta
Association between polymorphisms in genes related to DNA base-excision repair with risk and prognosis of oropharyngeal squamous cell carcinoma
Ericka Francislaine Dias Costa, Erika Stocco Santos, Vitor Teixeira Liutti, Frederico Leal, Vivian Castro Antunes Santos, José Augusto Rinck-Junior, Fernanda Viviane Mariano, Cláudia Malheiros Coutinho-Camillo, Albina Altemani, Carmen Silvia Passos Lima, Gustavo Jacob Lourenço
Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
Hanna Drzewiecka, Bartłomiej Gałęcki, Donata Jarmołowska-Jurczyszyn, Andrzej Kluk, Wojciech Dyszkiewicz, Paweł P. Jagodziński
Lack of TMEM27 expression is associated with postoperative progression of clinically localized conventional renal cell carcinoma
Andras Javorhazy, Nelli Farkas, Tamas Beothe, Csaba Pusztai, Arpad Szanto, Gyula Kovacs
Evaluation of assays for drug efficacy in a three-dimensional model of the lung
Julia M. Huber, Arno Amann, Stefan Koeck, Edith Lorenz, Jens M. Kelm, Petra Obexer, Heinz Zwierzina, Gabriele Gamerith
Distinct functional domains of PNMA5 mediate protein–protein interaction, nuclear localization, and apoptosis signaling in human cancer cells
Yong Hoi Lee, Siew Wai Pang, Chit Laa Poh, Kuan Onn Tan
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells
Mirjam Gerwing, Christine Jacobsen, Sergey Dyshlovoy, Jessica Hauschild, Tina Rohlfing, Christoph Oing, Simone Venz, Jan Oldenburg, Karin Oechsle, Carsten Bokemeyer, Gunhild von Amsberg, Friedemann Honecker
The Aurora kinase inhibitors in cancer research and therapy
Jonas Cicenas
Hematologic malignancies: newer strategies to counter the BCL-2 protein
Abdul Shukkur Ebrahim, Hussam Sabbagh, Allison Liddane, Ali Raufi, Mustapha Kandouz, Ayad Al-Katib
Clinical challenges with calcitonin-negative medullary thyroid carcinoma
Maria Teresa Samà, Ruth Rossetto Giaccherino, Marco Gallo, Francesco Felicetti, Francesca Maletta, Nadia Bonelli, Alessandro Piovesan, Nicola Palestini, Ezio Ghigo, Emanuela Arvat
Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB
Jizhuang Luo, Qingyuan Huang, Rui Wang, Baohui Han, Jie Zhang, Heng Zhao, Wentao Fang, Qingquan Luo, Jun Yang, Yunhai Yang, Lei Zhu, Tianxiang Chen, Xinghua Cheng, Yiyang Wang, Jiajie Zheng, Han Wu, Weicong Xia, Haiquan Chen
Characteristics and treatment of polycythemia vera patients in clinical practice: a multicenter chart review on 1476 individuals in Germany
Kathleen Jentsch-Ullrich, Judith Eberhardt, Vanja Zeremski, Michael Koehler, Denise Wolleschak, Florian H. Heidel
High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
Ji Soo Park, Hong Jae Chon, Hei-Cheul Jeung, Sang Joon Shin, Sun Young Rha, Joong Bae Ahn, Kang Young Lee, Nam Kyu Kim, Hyun Cheol Chung